The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Pompe Disease Treatment Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2016-2031)
Forecast CAGR (2023-2031): 3.8%
Growing awareness pertaining to genetic and rare disorders, including Pompe disease, is expected to drive the growth of the global Pompe disease treatment market. Increasing number of drugs in clinical trials by leading pharmaceutical companies for Pompe disease is expected to offer lucrative growth opportunities to the market. However, the rarity of the disease and limited patient population for clinical trials pose challenges for the Pompe disease treatment market.
Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/pompe-disease-treatment-market/requestsample
Advancements in diagnosis, such as newborn screening, genetic testing, and enzyme assays, have led to increased accuracy in detecting Pompe disease. These advancements in the field of diagnosis are expected to have a positive impact on global Pompe disease treatment market growth. Over the forecast period, the anticipated increase in the development of various drugs to combat Pompe disease is expected to drive the market growth. These developments, coupled with the growing demand for novel therapies and strengthening healthcare infrastructure, are likely to contribute to the market growth.
Pompe Disease Treatment Industry Definition and Major Segments
Pompe disease, also known as glycogen storage disease type II, is a rare genetic disorder caused by the deficiency of the acid alpha-glucosidase enzyme, leading to the accumulation of glycogen in the body’s cells, primarily affecting muscles and the heart.
Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/pompe-disease-treatment-market
Based on indication type, the market is segmented into:
- Infantile-Onset Pompe Disease (IOPD)
- Late-Onset Pompe Disease (LOPD)
- Others
Based on diagnosis type, the market is segmented into:
- Blood Tests
- Genetic Tests
- Prenatal Tests
- Others
Based on treatment type, the market is segmented into:
- Enzyme Replacement Therapy (ERT)
- Chaperone-Advanced Replacement Therapy (CHART)
- Gene Therapy
- Others
Based on route of administration, the market is classified into:
- Oral
- Parenteral
- Others
Based on end user, the market is bifurcated into:
- Hospitals
- Diagnostic Centres
- Ambulatory Surgical Centres
- Others
Based on region, the market is segregated into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Pompe Disease Treatment Market Trends
The key trends in the global Pompe disease treatment market include the growing development and research by the healthcare sector, aimed towards the development of different treatment options and targeted therapies to combat the disease. Significant advancements in genetic testing and newborn screening programs have resulted in the early detection of Pompe disease, which significantly impacts the clinical management of the patients.
Increased clinical trials with enzyme replacement therapies, gene therapies, and novel chaperone-advanced replacement therapies are projected to increase the market growth. These developments, along with the growing demand for personalized medicine and improvements in healthcare infrastructure, are expected to impact the growth of the market positively.
Key Market Players
The major players in the pompe disease treatment market report are:
- Amicus Therapeutics, Inc.
- BioMarin
- Genzyme (Sanofi)
- Audentes Therapeutics (Astellas Pharma Inc.)
- EpiVax, Inc
- Oxyrane
- Sangamo Therapeutics
- Bayer AG
- AVROBIO, Inc.
- Nova Biomedical
- Trinity Biotech
The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research (EMR) is a leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customizes syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work diligently to ensure that clients get only the most updated, relevant, accurate, and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact:
Company Name: Claight Corporation
Contact Person: Frara Prih, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
0 Comments:
Post a Comment